-
US households become increasingly strained in diverging economy
-
Four dead men: the cold case that engulfed a Colombian cycling star
-
Super Bowl stars stake claims for Olympic flag football
-
On a roll, Brazilian cinema seizes its moment
-
Rising euro, falling inflation in focus at ECB meeting
-
AI to track icebergs adrift at sea in boon for science
-
Indigenous Brazilians protest Amazon river dredging for grain exports
-
Google's annual revenue tops $400 bn for first time, AI investments rise
-
Last US-Russia nuclear treaty ends in 'grave moment' for world
-
Man City brush aside Newcastle to reach League Cup final
-
Guardiola wants permission for Guehi to play in League Cup final
-
Boxer Khelif reveals 'hormone treatments' before Paris Olympics
-
'Bad Boy,' 'Little Pablo' and Mordisco: the men on a US-Colombia hitlist
-
BHP damages trial over Brazil mine disaster to open in 2027
-
Dallas deals Davis to Wizards in blockbuster NBA trade: report
-
Iran-US talks back on, as Trump warns supreme leader
-
Lens cruise into French Cup quarters, Endrick sends Lyon through
-
No.1 Scheffler excited for Koepka return from LIV Golf
-
Curling quietly kicks off sports programme at 2026 Winter Olympics
-
Undav pokes Stuttgart past Kiel into German Cup semis
-
Germany goalkeeper Ter Stegen to undergo surgery
-
Bezos-led Washington Post announces 'painful' job cuts
-
Iran says US talks are on, as Trump warns supreme leader
-
Gaza health officials say strikes kill 24 after Israel says officer wounded
-
Empress's crown dropped in Louvre heist to be fully restored: museum
-
UK PM says Mandelson 'lied' about Epstein relations
-
Shai to miss NBA All-Star Game with abdominal strain
-
Trump suggests 'softer touch' needed on immigration
-
From 'flop' to Super Bowl favorite: Sam Darnold's second act
-
Man sentenced to life in prison for plotting to kill Trump in 2024
-
Native Americans on high alert over Minneapolis crackdown
-
Dallas deals Davis to Wizards in blockbuster NBA deal: report
-
Russia 'no longer bound' by nuclear arms limits as treaty with US ends
-
Panama hits back after China warns of 'heavy price' in ports row
-
Strike kills guerrillas as US, Colombia agree to target narco bosses
-
Wildfire smoke kills more than 24,000 Americans a year: study
-
Telegram founder slams Spain PM over under-16s social media ban
-
Curling kicks off sports programme at 2026 Winter Olympics
-
Preventative cholera vaccination resumes as global supply swells: WHO
-
Wales' Macleod ready for 'physical battle' against England in Six Nations
-
Xi calls for 'mutual respect' with Trump, hails ties with Putin
-
'All-time great': Maye's ambitions go beyond record Super Bowl bid
-
Shadow over Vonn as Shiffrin, Odermatt headline Olympic skiing
-
US seeks minerals trade zone in rare Trump move with allies
-
Ukraine says Abu Dhabi talks with Russia 'substantive and productive'
-
Brazil mine disaster victims in London to 'demand what is owed'
-
AI-fuelled tech stock selloff rolls on
-
Russia vows to act 'responsibly' as nuclear pact ends with US
-
White says time at Toulon has made him a better Scotland player
-
Washington Post announces 'painful' job cuts
Long Covid symptoms affect one in eight, study suggests
One in eight people who get coronavirus develop at least one symptom of long Covid, one of the most comprehensive studies on the condition to date suggested on Thursday.
With more than half a billion coronavirus cases recorded worldwide since the start of the pandemic, there has been rising concern about the lasting symptoms seen in people with long Covid.
However almost none of the existing research has compared long Covid sufferers with people who have never been infected, making it possible that some of the health problems were not caused by the virus.
A new study published in The Lancet journal asked more than 76,400 adults in the Netherlands to fill out an online questionnaire on 23 common long Covid symptoms.
Between March 2020 and August 2021, each participant filled out the questionnaire 24 times.
During that period, more than 4,200 of them -- 5.5 percent -- reported catching Covid.
Of those with Covid, over 21 percent had at least one new or severely increased symptom three to five months after becoming infected.
However nearly nine percent of a control group which did not have Covid reported a similar increase.
This suggested that 12.7 percent of those who had Covid -- around one in eight -- suffered from long-term symptoms, the study said.
The research also recorded symptoms before and after Covid infection, allowing the researchers to further pinpoint exactly what was related to the virus.
It found that common long Covid symptoms include chest pain, breathing difficulties, muscle pain, loss of taste and smell, and general fatigue.
- 'Major advance' -
One of the study's authors, Aranka Ballering of the Dutch University of Groningen, said long Covid was "an urgent problem with a mounting human toll".
"By looking at symptoms in an uninfected control group and in individuals both before and after SARS-CoV-2 infection, we were able to account for symptoms which may have been a result of non-infectious disease health aspects of the pandemic, such as stress caused by restrictions and uncertainty," she said.
The authors of the study said its limitations included that it did not cover later variants, such as Delta or Omicron, and did not collect information about some symptoms such as brain fog, which have since been considered a common sign of long Covid.
Another study author, Judith Rosmalen, said "future research should include mental health symptoms" such as depression and anxiety, as well as aspects like brain fog, insomnia and a feeling of malaise after even minor exertion.
Christopher Brightling and Rachael Evans, experts from Britain's Leicester University who were not involved in the study, said it was "a major advance" on previous long Covid research because it had an uninfected control group.
"Encouragingly, emerging data from other studies" suggests there is a lower rate of long Covid in people who have been vaccinated or infected with the Omicron variant, they said in a linked Lancet comment.
D.AbuRida--SF-PST